The Neuropathology Core is designed to serve as a University-wide resource for investigators in need of Alzheimer's Disease brain tissue for their studies. The mission of this Core is to provide accurate post-mortem diagnoses to participating clinicians, human autopsy tissue for researchers, and collect post-mortem tissue for a wide range of scientific endeavors to include anatomical, neuropathological and molecular biological studies.
The Specific Aims of this Core are as follows:
Specific Aim 1 will collect, catalog and preserve a minimum of 100 (30% black; 70% white) control, 50-125 AD (patients followed in the ADCC), and 100 outside brains.
Specific Aim 2 will provide a precise pathological diagnosis on brains collected in Specific Aim 1 using NINCDS and CERAD criteria.
Specific Aim 3 will provide precisely dissected brain tissue specimens to Core utilizers.
Specific Aim 4 will provide technical expertise in microtomy, quantitative histochemistry, microscopic anatomy and immunocytochemistry to all Core utilizers.
Specific Aim 5 will oversee the management of qualitative and quantitative neuropathology data.
Specific Aim 6 will educate other investigators about the availability of this resource. Specifically, this unit will serve as a resource of fresh frozen and fixed tissue, histochemical and immunocytochemical methodology which will be made available to all investigators meeting Core utilization requirements.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG010163-05S1
Application #
6234324
Study Section
Project Start
1997-09-30
Project End
1998-06-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Bambara, Jennifer K; Griffith, H Randall; Martin, Roy C et al. (2007) Medical decision-making abilities in older adults with chronic partial epilepsy. Epilepsy Behav 10:63-8
Griffith, H R; Dymek, M P; Atchison, P et al. (2005) Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment. Neurology 65:483-5
Marson, D C (2001) Loss of competency in Alzheimer's disease: conceptual and psychometric approaches. Int J Law Psychiatry 24:267-83
Dymek, M P; Atchison, P; Harrell, L et al. (2001) Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology 56:17-24
Marson, D C; Earnst, K S; Jamil, F et al. (2000) Consistency of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease. J Am Geriatr Soc 48:911-8
Earnst, K S; Marson, D C; Harrell, L E (2000) Cognitive models of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease. J Am Geriatr Soc 48:919-27
Marson, D; Harrell, L (1999) Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease. Semin Clin Neuropsychiatry 4:41-9
Marson, D C; Annis, S M; McInturff, B et al. (1999) Error behaviors associated with loss of competency in Alzheimer's disease. Neurology 53:1983-92
Deutsch, G; Mountz, J M; Katholi, C R et al. (1997) Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 38:6-13
Oh, Y; Lee, Y J; Waxman, S G (1997) Regulation of Na+ channel beta 1 and beta 2 subunit mRNA levels in cultured rat astrocytes. Neurosci Lett 234:107-10

Showing the most recent 10 out of 24 publications